Advertisement

Topics

Gilead Pledges 2.4 Million Annual Dose Donations of Drug to End HIV in the U.S.

20:00 EDT 9 May 2019 | BioSpace

The company is pledging to support a goal to end HIV in the U.S. by 2030 announced by the president during the State of the Union earlier this year.

Original Article: Gilead Pledges 2.4 Million Annual Dose Donations of Drug to End HIV in the U.S.

NEXT ARTICLE

More From BioPortfolio on "Gilead Pledges 2.4 Million Annual Dose Donations of Drug to End HIV in the U.S."

Advertisement
Quick Search
Advertisement
Advertisement